{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T19:25:06Z","timestamp":1790364306111,"version":"4.1.0"},"reference-count":40,"publisher":"American Medical Association (AMA)","issue":"14","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2021,10,12]]},"DOI":"10.1001\/jama.2021.15161","type":"journal-article","created":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T11:54:23Z","timestamp":1630583663000},"page":"1400","source":"Crossref","is-referenced-by-count":211,"title":["Estimated US Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence Based on Blood Donations, July 2020-May 2021"],"prefix":"10.1001","volume":"326","author":[{"given":"Jefferson M.","family":"Jones","sequence":"first","affiliation":[{"name":"COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mars","family":"Stone","sequence":"additional","affiliation":[{"name":"Vitalant Research Institute, San Francisco, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasan","family":"Sulaeman","sequence":"additional","affiliation":[{"name":"Vitalant Research Institute, San Francisco, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca V.","family":"Fink","sequence":"additional","affiliation":[{"name":"Westat, Rockville, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honey","family":"Dave","sequence":"additional","affiliation":[{"name":"Vitalant Research Institute, San Francisco, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew E.","family":"Levy","sequence":"additional","affiliation":[{"name":"Westat, Rockville, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Di Germanio","sequence":"additional","affiliation":[{"name":"Vitalant Research Institute, San Francisco, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie","family":"Green","sequence":"additional","affiliation":[{"name":"Creative Testing Solutions, Temple, Arizona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Notari","sequence":"additional","affiliation":[{"name":"Scientific Affairs, American Red Cross, Rockville, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Saa","sequence":"additional","affiliation":[{"name":"Scientific Affairs, American Red Cross, Gaithersburg, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brad J.","family":"Biggerstaff","sequence":"additional","affiliation":[{"name":"COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna","family":"Strauss","sequence":"additional","affiliation":[{"name":"New York Blood Center, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debra","family":"Kessler","sequence":"additional","affiliation":[{"name":"New York Blood Center, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph","family":"Vassallo","sequence":"additional","affiliation":[{"name":"Vitalant Research Institute, San Francisco, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Reik","sequence":"additional","affiliation":[{"name":"OneBlood, St Petersburg, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Rossmann","sequence":"additional","affiliation":[{"name":"Gulf Coast Regional Blood Center, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Destree","sequence":"additional","affiliation":[{"name":"Bloodworks Northwest, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim-Anh","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Blood Bank of Hawaii, Honolulu"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merlyn","family":"Sayers","sequence":"additional","affiliation":[{"name":"Carter BloodCare, Bedford, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Lough","sequence":"additional","affiliation":[{"name":"LifeSouth Community Blood Centers, Gainesville, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel W.","family":"Bougie","sequence":"additional","affiliation":[{"name":"Versiti, Milwaukee, Wisconsin"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Ritter","sequence":"additional","affiliation":[{"name":"Blood Bank of Alaska, Anchorage"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerardo","family":"Latoni","sequence":"additional","affiliation":[{"name":"Banco de Sangre de Servicios Mutuos, San Juan, Puerto Rico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Billy","family":"Weales","sequence":"additional","affiliation":[{"name":"The Blood Center, New Orleans, Louisiana"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacy","family":"Sime","sequence":"additional","affiliation":[{"name":"LifeServe, Des Moines, Iowa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jed","family":"Gorlin","sequence":"additional","affiliation":[{"name":"Innovative Blood Resources, St Paul, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole E.","family":"Brown","sequence":"additional","affiliation":[{"name":"COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn V.","family":"Gould","sequence":"additional","affiliation":[{"name":"COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Berney","sequence":"additional","affiliation":[{"name":"COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina J.","family":"Benoit","sequence":"additional","affiliation":[{"name":"COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maureen J.","family":"Miller","sequence":"additional","affiliation":[{"name":"COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dane","family":"Freeman","sequence":"additional","affiliation":[{"name":"Georgia Tech Research Institute, Atlanta"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deeksha","family":"Kartik","sequence":"additional","affiliation":[{"name":"Georgia Tech Research Institute, Atlanta"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia M.","family":"Fry","sequence":"additional","affiliation":[{"name":"COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Azziz-Baumgartner","sequence":"additional","affiliation":[{"name":"COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aron J.","family":"Hall","sequence":"additional","affiliation":[{"name":"COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"MacNeil","sequence":"additional","affiliation":[{"name":"COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adi V.","family":"Gundlapalli","sequence":"additional","affiliation":[{"name":"COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sridhar V.","family":"Basavaraju","sequence":"additional","affiliation":[{"name":"COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan I.","family":"Gerber","sequence":"additional","affiliation":[{"name":"COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica E.","family":"Patton","sequence":"additional","affiliation":[{"name":"COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Custer","sequence":"additional","affiliation":[{"name":"Vitalant Research Institute, San Francisco, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillip","family":"Williamson","sequence":"additional","affiliation":[{"name":"Creative Testing Solutions, Temple, Arizona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham","family":"Simmons","sequence":"additional","affiliation":[{"name":"Vitalant Research Institute, San Francisco, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie J.","family":"Thornburg","sequence":"additional","affiliation":[{"name":"COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Kleinman","sequence":"additional","affiliation":[{"name":"University of British Columbia, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan L.","family":"Stramer","sequence":"additional","affiliation":[{"name":"Scientific Affairs, American Red Cross, Gaithersburg, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Opsomer","sequence":"additional","affiliation":[{"name":"Westat, Rockville, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P.","family":"Busch","sequence":"additional","affiliation":[{"name":"Vitalant Research Institute, San Francisco, California"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"12","key":"joi210100r2","doi-asserted-by":"publisher","first-page":"e1010","DOI":"10.1093\/cid\/ciaa1780","article-title":"Estimated incidence of coronavirus disease 2019 (COVID-19) illness and hospitalization: United States, February-September, 2020.","volume":"72","author":"Reese","year":"2021","journal-title":"Clin Infect Dis"},{"key":"joi210100r3","article-title":"Lack of antibodies to SARS-CoV-2 in a large cohort of previously infected persons.","author":"Petersen","journal-title":"Clin Infect Dis"},{"issue":"2","key":"joi210100r4","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1093\/cid\/ciaa1116","article-title":"Serosurveillance for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) incidence using global blood donor populations.","volume":"72","author":"Busch","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"14","key":"joi210100r5","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1056\/NEJMc2101667","article-title":"Antibody responses in seropositive persons after a single dose of SARS-CoV-2 mRNA vaccine.","volume":"384","author":"Krammer","year":"2021","journal-title":"N Engl J Med"},{"issue":"16","key":"joi210100r8","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1001\/jama.2020.18598","article-title":"Change in donor characteristics and antibodies to SARS-CoV-2 in donated blood in the US, June-August 2020.","volume":"324","author":"Dodd","year":"2020","journal-title":"JAMA"},{"key":"joi210100r14","article-title":"Use of US blood donors for national serosurveillance of SARS-CoV-2 antibodies: basis for an expanded national donor serosurveillance program.","author":"Stone","journal-title":"Clin Infect Dis"},{"issue":"31","key":"joi210100r15","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abh3409","article-title":"SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assay.","volume":"7","author":"Peluso","year":"2021","journal-title":"Sci Adv"},{"issue":"11","key":"joi210100r17","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1093\/infdis\/jiaa523","article-title":"Are seroprevalence estimates for severe acute respiratory syndrome coronavirus 2 biased?","volume":"222","author":"Takahashi","year":"2020","journal-title":"J Infect Dis"},{"issue":"8","key":"joi210100r19","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1111\/trf.2011.51.issue-8","article-title":"Healthy donor effect: its magnitude in health research among blood donors.","volume":"51","author":"Atsma","year":"2011","journal-title":"Transfusion"},{"issue":"3","key":"joi210100r21","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1177\/096228029600500305","article-title":"Variance estimation for complex surveys using replication techniques.","volume":"5","author":"Rust","year":"1996","journal-title":"Stat Methods Med Res"},{"issue":"6","key":"joi210100r22","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/s41577-021-00550-x","article-title":"Prospects for durable immune control of SARS-CoV-2 and prevention of reinfection.","volume":"21","author":"Cromer","year":"2021","journal-title":"Nat Rev Immunol"},{"issue":"7","key":"joi210100r25","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1038\/s41591-021-01377-8","article-title":"Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection.","volume":"27","author":"Khoury","year":"2021","journal-title":"Nat Med"},{"key":"joi210100r26","article-title":"COVID-19 breakthrough infections in vaccinated health care workers.","author":"Bergwerk","journal-title":"N Engl J Med"},{"issue":"28","key":"joi210100r27","doi-asserted-by":"publisher","first-page":"985","DOI":"10.15585\/mmwr.mm7028a1","article-title":"COVID-19 vaccination coverage among insured persons aged =16 years, by race\/ethnicity and other selected characteristics - eight integrated health care organizations, United States, December 14, 2020-May 15, 2021.","volume":"70","author":"Pingali","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"10259","key":"joi210100r28","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1016\/S0140-6736(20)32009-2","article-title":"Prevalence of SARS-CoV-2 antibodies in a large nationwide sample of patients on dialysis in the USA: a cross-sectional study.","volume":"396","author":"Anand","year":"2020","journal-title":"Lancet"},{"issue":"4","key":"joi210100r29","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1001\/jamainternmed.2020.7976","article-title":"Estimated SARS-CoV-2 seroprevalence in the US as of September 2020.","volume":"181","author":"Bajema","year":"2020","journal-title":"JAMA Intern Med"},{"issue":"43","key":"joi210100r30","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.15585\/mmwr.mm6943e4","article-title":"COVID-19 mitigation behaviors by age group: United States, April-June 2020.","volume":"69","author":"Hutchins","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"10","key":"joi210100r31","doi-asserted-by":"publisher","first-page":"3251","DOI":"10.1016\/j.jaip.2020.08.026","article-title":"Age-related differences in immunological responses to SARS-CoV-2.","volume":"8","author":"Wong","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"5152","key":"joi210100r34","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.15585\/mmwr.mm695152a3","article-title":"Performance of an antigen-based test for asymptomatic and symptomatic SARS-CoV-2 testing at two university campuses: Wisconsin, September-October 2020.","volume":"69","author":"Pray","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"3","key":"joi210100r36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0033056","article-title":"Incidence of H1N1 2009 virus infection through the analysis of paired plasma specimens among blood donors, France.","volume":"7","author":"Bone","year":"2012","journal-title":"PLoS One"},{"issue":"25","key":"joi210100r37","doi-asserted-by":"publisher","first-page":"922","DOI":"10.15585\/mmwr.mm7025e1","article-title":"COVID-19 vaccination coverage among adults: United States, December 14, 2020-May 22, 2021.","volume":"70","author":"Diesel","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"9","key":"joi210100r38","doi-asserted-by":"publisher","first-page":"2899","DOI":"10.1111\/trf.v59.9","article-title":"Sociodemographic and behavioral characteristics associated with blood donation in the United States: a population-based study.","volume":"59","author":"Patel","year":"2019","journal-title":"Transfusion"},{"issue":"22","key":"joi210100r39","doi-asserted-by":"publisher","first-page":"818","DOI":"10.15585\/mmwr.mm7022e1","article-title":"Patterns in COVID-19 vaccination coverage, by social vulnerability and urbanicity: United States, December 14, 2020-May 1, 2021.","volume":"70","author":"Barry","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"joi210100r40","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.36462","article-title":"Association of social and demographic factors with COVID-19 incidence and death rates in the US.","volume":"4","author":"Karmakar","year":"2021","journal-title":"JAMA Netw Open"},{"key":"joi210100r9"},{"key":"joi210100r10"},{"key":"joi210100r11"},{"key":"joi210100r12"},{"key":"joi210100r13"},{"key":"joi210100r1","unstructured":"Centers for Disease Control and Prevention. COVID data tracker. Accessed July 30, 2021. https:\/\/covid.cdc.gov\/covid-data-tracker\/"},{"key":"joi210100r6","unstructured":"National Institutes of Health. COVID-19 SeroHub. Accessed July 30, 2021. https:\/\/covid19serohub.nih.gov\/"},{"key":"joi210100r7","unstructured":"World Health Organization. SeroTracker. Accessed June 17, 2021. https:\/\/serotracker.com\/"},{"key":"joi210100r16","unstructured":"US Food and Drug Administration. Individual EUAs for serology and other adaptive immune response tests for SARS-CoV-2. Accessed March 26, 2021. https:\/\/www.fda.gov\/medical-devices\/coronavirus-disease-2019-covid-19-emergency-use-authorizations-medical-devices\/in-vitro-diagnostics-euas-serology-and-other-adaptive-immune-response-tests-sars-cov-2#individual-serological"},{"key":"joi210100r18","unstructured":"Centers for Disease Control and Production. US COVID-19 vaccine product information. Accessed July 30, 2021. https:\/\/www.cdc.gov\/vaccines\/covid-19\/info-by-product\/index.html"},{"key":"joi210100r20","unstructured":"US Census Bureau. American Community Survey data. Accessed December 10, 2020. https:\/\/www.census.gov\/programs-surveys\/acs\/data.html"},{"key":"joi210100r23","unstructured":"Centers for Disease Control and Prevention. Science brief: COVID-19 vaccines and vaccination. Accessed July 16, 2021. https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/science\/science-briefs\/fully-vaccinated-people.html"},{"key":"joi210100r24","doi-asserted-by":"crossref","unstructured":"Feng? S, Phillips? DJ, White? T, ; Oxford COVID Vaccine Trial Group. Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection.? medRxiv. Published June 24, 2021. doi:10.1101\/2021.06.21.21258528","DOI":"10.1101\/2021.06.21.21258528"},{"key":"joi210100r32","unstructured":"Centers for Disease Control and Prevention. Interim guidance for SARS-CoV-2 testing and screening at institutions of higher education (IHEs). Accessed July 30, 2021. https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/community\/colleges-universities\/ihe-testing.html"},{"key":"joi210100r33","unstructured":"Centers for Disease Control and Prevention. Testing guidelines for nursing homes. Accessed July 30, 2021. https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/hcp\/nursing-homes-testing.html"},{"key":"joi210100r35","unstructured":"US Food and Drug Administration. Updated information for blood establishments regarding the COVID-19 pandemic and blood donation. Accessed March 30, 2021. https:\/\/www.fda.gov\/vaccines-blood-biologics\/safety-availability-biologics\/updated-information-blood-establishments-regarding-covid-19-pandemic-and-blood-donation"}],"container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/articlepdf\/2784013\/jama_jones_2021_oi_210100_1633976009.39994.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,17]],"date-time":"2021-10-17T17:32:02Z","timestamp":1634491922000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2784013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,12]]},"references-count":40,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2021,10,12]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2021.15161","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.740743434.793589687","asserted-by":"object"}]},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10,12]]}}}